Gordon Brandt, Executive VP of Science and Clinica at NASTECH PHARMACEUTICAL CO INC (NSTK), sold 1,685 shares at $18.34 ($31K) on 2006-03-27, disclosed to the SEC on 2006-03-28.
Open-market sale of $31k NSTK by Executive VP of Science and Clinica. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| NSTK | SELL | 2007-01-05 | $73K | — | Filing → |
| NSTK | SELL | 2006-12-22 | $11K | — | Filing → |
| NSTK | SELL | 2006-12-07 | $81K | — | Filing → |